000 | 01283 a2200361 4500 | ||
---|---|---|---|
005 | 20250514160841.0 | ||
264 | 0 | _c20031120 | |
008 | 200311s 0 0 eng d | ||
022 | _a0093-7754 | ||
024 | 7 |
_a10.1016/s0093-7754(03)00357-9 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLogothetis, Christopher J | |
245 | 0 | 0 |
_aThe case for a biologically based classification of prostate cancer. _h[electronic resource] |
260 |
_bSeminars in oncology _cOct 2003 |
||
300 |
_a562-6 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAndrogen Antagonists _xtherapeutic use |
650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
650 | 0 | 4 | _aCocarcinogenesis |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 | _aDisease Progression |
650 | 0 | 4 |
_aGenetic Predisposition to Disease _xclassification |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMolecular Biology _xmethods |
650 | 0 | 4 |
_aMutation _xgenetics |
650 | 0 | 4 | _aPatient Care Team |
650 | 0 | 4 | _aPatient Selection |
650 | 0 | 4 | _aProstatectomy |
650 | 0 | 4 |
_aProstatic Neoplasms _xclassification |
773 | 0 |
_tSeminars in oncology _gvol. 30 _gno. 5 _gp. 562-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0093-7754(03)00357-9 _zAvailable from publisher's website |
999 |
_c14313877 _d14313877 |